Glycyrrhizic acid 甘草酸; Glycyrrhizin|cas:1405-86-3|西域试剂

Glycyrrhizic acid 甘草酸; Glycyrrhizin,98.0%

产品编号：Bellancom-N0184| CAS NO：1405-86-3| 分子式：C₄₂H₆₂O₁₆| 分子量：822.93

Glycyrrhizic acid (NSC 167409) 是一种直接的高迁移率族蛋白1(HMGB1)的抑制剂，抑制依赖于HMGB1的炎症分子表达和氧化应激反应。Glycyrrhizic acid的生物活性代谢物是甘草次酸，Glycyrrhizic acid是11-β-羟基类固醇脱氢酶有效抑制剂。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
Bellancom-N0184	￥500.00	杭州北京（现货）
Bellancom-N0184	￥700.00	杭州北京（现货）
Bellancom-N0184	￥1000.00	杭州北京（现货）
Bellancom-N0184	￥2100.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

Glycyrrhizic acid 甘草酸; Glycyrrhizin

产品介绍

Glycyrrhizic acid 是甘草里面的活性成分三萜皂苷，为 HMGB1 的拮抗剂，有用于肿瘤、糖尿病等研究的潜力。

生物活性

Glycyrrhizic acid is a triterpenoid saponinl, acting as a direct HMGB1 antagonist, with anti-tumor, anti-diabetic activities.

体外研究

Glycyrrhizic acid shows a series of anti-cancer-related pharmacological activities, such as broad-spectrum anti-cancer ability, resistance to the tissue toxicity caused by chemotherapy and radiation, drug absorption enhancing effects and anti-multidrug resistance (MDR) mechanisms, as a carrier material in drug delivery systems.
In intestinal NCI-H716 cells that secretes GLP-1, Glycyrrhizic acid promotes GLP-1 secretion with a marked elevation of calcium levels. Glycyrrhizic acid can enhance GLP-1 secretion through TGR5 activation.
Glycyrrhizic acid can form a stable transparent low-molecular-weight hydrogels (LMWHs) at 37°C in physiological phosphate buffered saline (PBS) with nanoclusters as the microstructures^[4].

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

In type 1-like diabetic rats induced by streptozotocin (STZ-treated rats), Glycyrrhizic acid increases the level of plasma GLP-1, which is blocked by triamterene at a dose sufficient to inhibit Takeda G-protein-coupled receptor 5 (TGR5). Glycyrrhizic acid (Glycyrrhizic acid; 50 mg/kg, i.p.) significantly decreases the levels of TgAb, HMGB1, TNF-α, IL-6, IL-1β in mice.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

性状

Solid

溶解性数据

In Vitro:

DMSO : 100 mg/mL (121.52 mM; Need ultrasonic)

H₂O : < 0.1 mg/mL (insoluble)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	1.2152 mL	6.0759 mL	12.1517 mL
5 mM	0.2430 mL	1.2152 mL	2.4303 mL
10 mM	0.1215 mL	0.6076 mL	1.2152 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 2.5 mg/mL (3.04 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (3.04 mM，饱和度未知) 的澄清溶液。
以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。
将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (3.04 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (3.04 mM，饱和度未知) 的澄清溶液。
以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。
将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil
Solubility: ≥ 2.5 mg/mL (3.04 mM); Clear solution

此方案可获得 ≥ 2.5 mg/mL (3.04 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。
以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在西域网站选购。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

参考文献

. Su X, et al. Glycyrrhizic acid: A promising carrier material for anticancer therapy. Biomed Pharmacother. 2017 Sep 5;95:670-678 [Content Brief]

. Wang LY, et al. Glycyrrhizic acid increases glucagon like peptide-1 secretion via TGR5 activation in type 1-like diabetic rats. Biomed Pharmacother. 2017 Sep 4;95:599-604. [Content Brief]

. Li C, et al. Glycyrrhizin, a Direct HMGB1 Antagonist, Ameliorates Inflammatory Infiltration in a Model of Autoimmune Thyroiditis via Inhibition of TLR2-HMGB1 Signaling. Thyroid. 2017 May;27(5):722-731. [Content Brief]

[4]. Xia Zhao, et al. A Simple Injectable Moldable Hydrogel Assembled from Natural Glycyrrhizic Acid with Inherent Antibacterial Activity. ACS Appl. Bio Mater. 2020, 3, 1, 648–653.

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

产品编号(Item Number)

批号(Lot Number)

安全声明 (欧洲)	S22-S24/25
危险品运输编码	NONH for all modes of transport
RTECS号	MD2025000
海关编码	1211903600

1. 物质的识别

产品名：	Glycyrrhizic acid
CAS号：	1405-86-3
制造商/供应商：	西域试剂网站：www.hzbp.cn 邮件：13911702513@139.com

2. 合成/成分数据

产品名：	Glycyrrhizic acid
别名：	NSC 167409; Glycyrrhizin
分子式：	C42H62O16
分子量：	822.94

3. 急救措施

吸入后：	如果吸入，移至空气新鲜处，如果呼吸困难，给输氧，如呼吸停止，给予人工呼吸。
皮肤接触后：	用大量的水冲洗，移除污染的衣服和鞋子。
眼睛接触后：	检查并取下隐形眼镜，并用大量的水冲洗；呼叫医生。
吞食后：	如果吞食，用大量纯净水漱口；呼叫医生。

4. 消防措施

适当的灭火剂：	雾状水，二氧化碳，干粉或泡沫。
防护设备：	穿戴自给式呼吸器和防护服，以防止与皮肤和眼睛接触。

5. 泄漏应急处理

安全防范措施：	封锁泄漏区域；穿戴自给式呼吸器，防护服和厚橡胶手套。
清洁/收集措施：	使用液体粘合原料（硅藻土，通用粘合剂）吸取精细粉末；使用酒精擦洗表面和设备除去污渍；根据第11条处理被污染的材料。

6. 处理和储存

安全处理说明：	避免吸入和接触皮肤，眼睛及衣物；材料可能略微具有刺激性。
储存：	2-8°C, dry, protect from light, sealed

7. 接触控制和个人防护

呼吸设备：	NIOSH / MSHA认可的呼吸器。
双手保护：	耐化学腐蚀的橡胶手套。
眼睛防护：	化学安全护目镜。

8. 稳定性和反应活性

稳定性：	按照说明存储是稳定的；避免强氧化剂。
热分解/其他要避免的情况：	避免光和热。

9. 毒性资料

急性毒性：	无可用资料。
主要刺激性影响：	无可用资料。
在皮肤上：	无可用资料。
对眼睛：	无可用资料；可能具有刺激性。

10. 生态资料

一般注意事项：

无可用资料。

11. 废弃处置

按照所在国家，省份，县市和地方的法规处置。

12. 运输信息

正确的运输名称：	无
非危险品运输：	这种物质被视为非危险品运输。

13. 法规信息

尚未有针对此产品作出的化学安全性评估。

14. 其他信息

30430-55-8

1405-86-3

文献：Chemical and Pharmaceutical Bulletin, , vol. 42, # 5 p. 1016 - 1027

149553-79-7

1405-86-3

文献：Chemical and Pharmaceutical Bulletin, , vol. 42, # 5 p. 1016 - 1027

60192-37-2

1405-86-3

文献：Chemical and Pharmaceutical Bulletin, , vol. 42, # 5 p. 1016 - 1027

上游产品 3
30430-55-8 149553-79-7 60192-37-2
下游产品 3
6556-12-3 471-53-4 53-96-3

102. [5.56] Liu Zidi et al."Abiotic factors and endophytes co-regulate flavone and terpenoid glycoside metabolism in Glycyrrhiza uralensis."APPLIED MICROBIOLOGY AND BIOTECHNOLOGY.2023 Mar;:1-18

101. [6.449] Wentao Li et al."Optimization, characterization of Astragalus polysaccharides, and evaluation of anti-inflammation effect in primary cultured astrocytes via HMGB1/RAGE/NF-κB/NLRP3 signal pathway."INDUSTRIAL CROPS AND PRODUCTS.2023 Jul;197:116594

100. [1.911] Xialin Chen et al."The tissue distribution of Jinzhen oral liquid in healthy and influenza mice."BIOMEDICAL CHROMATOGRAPHY.2023 Mar;:e5605

99. [3.571] Li Song et al."Structural identification and comprehensive comparison of saponin-related impurities present in the three different Compound Glycyrrhizin Tablets."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2023 Feb;:115287

98. [9.417] Yuqin Yang et al."Natural small molecule self-assembled hydrogel inhibited tumor growth and lung metastasis of 4T1 breast cancer by regulating the CXCL1/2-S100A8/9 axis."MATERIALS & DESIGN.2022 Nov;:111435

97. [IF=2.65] Bin Wang et al."Xiaoqinglong Decoction Enhances Autophagy to Antagonist Airway Inflammation Induced by Cold in Asthmatic Rats."Evidence-based Complementary and Alternative Medicine.2022 Oct 25;2022:3943343

96. [IF=5.195] Xiaoshan Zhao et al."Gancao Fuzi decoction regulates the Th17/Treg cell imbalance in rheumatoid arthritis by targeting Foxp3 via miR-34a."JOURNAL OF ETHNOPHARMACOLOGY.2023 Jan;301:115837

95. [IF=6.78] Sai Wang et al."Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet."LIFE SCIENCES.2022 Dec;310:121110

94. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199

93. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231

92. [IF=6.819] Chunjing Guo et al."A novel saponin liposomes based on the couplet medicines of Platycodon grandiflorum–Glycyrrhiza uralensis for targeting lung cancer."DRUG DELIVERY

91. [IF=5.988] Shichang Zhang et al."A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats."Frontiers in Pharmacology.2022; 13: 891829

90. [IF=1.978] Chen Ming-jun et al."Composite Sophora Colon-Soluble Capsule Ameliorates DSS-Induced Ulcerative Colitis in Mice via Gut Microbiota-Derived Butyric Acid and NCR+ ILC3."Chin J Integr Med. 2022 Apr;:1-10

89. [IF=2.63] Zhou Peng et al."Exploring the Mechanism of Ling-Gui-Zhu-Gan Decoction in Ventricular Remodeling after Acute Myocardial Infarction Based on UPLC and In Vivo Experiments."Evidence-based Complementary and Alternative Medicine. 2022;2022:8593176

88. [IF=5.34] Dong Shao et al."Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology."PHYTOMEDICINE. 2022 Jul;102:154177

87. [IF=5.221] Yuqin Yang et al."Revealing the Toxicity-Enhancing Essence of Glycyrrhiza on Genkwa Flos Based on Ultra-high-performance Liquid Chromatography Coupled With Quadrupole-Orbitrap High-Resolution Mass Spectrometry and Self-Assembled Supramolecular Technology.

86. [IF=4.36] Shasha Kong et al."Synergistic mechanism for the bioactivity fortification of licorice by honey."J Ethnopharmacol. 2022 May;289:115048

85. [IF=1.902] Jia Wang et al."Investigate the effect of honey on the absorption of seven active ingredients from wu-tou decoction in rats."Biomedical Chromatography. 2022 Jan 06

84. [IF=6.4] Yee Huang et al."Outer Membrane Vesicles Coating Nano-Glycyrrhizic Acid Confers Protection Against Borderella bronchiseptica Through Th1/Th2/Th17 Responses."Int J Nanomed. 2022 Feb;17:647-663

83. [IF=5.545] Yuxuan Han et al."Multi-dimensional "projection" - the impact of abiotic stresses on the content of seven active compounds and expression of related genes in Glycyrrhiza uralensis Fisch."Environ Exp Bot. 2022 May;197:104846

82. [IF=5.165] Juanning Ren et al."Qualitative and quantitative analysis of multi-components in Xing-Su-Ning Capsules for quality improvement."Arab J Chem. 2022 Jun;15:103825

81. [IF=1.638] Sunhong Yan et al."Protective effect of glycyrrhizic acid on cerebral ischemia/reperfusion injury via inhibiting HMGB1‐mediated TLR4/NF‐κB pathway."Biotechnol Appl Bioc. 2019 Nov;66(6):1024-1030

80. [IF=1.885] Xia Wenxin et al."Study on the Spectrum-Effect Relationship of the Traditional Effect of Saponins in Glycyrrhiza uralensis Fisch."Int J Anal Chem. 2021;2021:6617033

79. [IF=1.902] Chenxi Wang et al."Multiple component-pharmacokinetic studies on 10 bioactive constituents of Peiyuan Tongnao capsule using parallel reaction monitoring mode."Biomed Chromatogr. 2021 Oct;35(10):e5153

78. [IF=2.629] Li Tingting et al."Quality Assessment of Licorice Based on Quantitative Analysis of Multicomponents by Single Marker Combined with HPLC Fingerprint."Evid-Based Compl Alt. 2021;2021:8834826

77. [IF=3] Wan Haoyu et al."Pharmacokinetics of seven major active components of Mahuang decoction in rat blood and brain by LC–MS/MS coupled to microdialysis sampling."N-S Arch Pharmacol. 2020 Aug;393(8):1559-1571

76. [IF=3.361] Lin Sun et al."Rapid characterization of chemical constituents of Shaoyao Gancao decoction using UHPLC coupled with Fourier transform ion cyclotron resonance mass spectrometry."Rsc Adv. 2020 Aug;10(49):29528-29535

75. [IF=3.361] Yuhao Zhang et al."An integrated approach for structural characterization of Gui Ling Ji by traveling wave ion mobility mass spectrometry and molecular network."Rsc Adv. 2021 Apr;11(26):15546-15556

74. [IF=3.645] Jie Lu et al."Identification and determination of chemical constituents from Yinchen Qingjin granules by ultra high-performance liquid chromatography coupled with linear ion trap-Orbitrap mass spectrometry."J Sep Sci. 2021 Apr;44(7):1324-1344

73. [IF=3.69] Qian Zhang et al."Qishen Granule alleviates endoplasmic reticulum stress-induced myocardial apoptosis through IRE-1-CRYAB pathway in myocardial ischemia."J Ethnopharmacol. 2020 Apr;252:112573

72. [IF=3.69] Xiaoping Wang et al."Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats."J Ethnopharmacol. 2020 Apr;252:112536

71. [IF=3.935] Zhengchao Ji et al."Global identification and quantitative analysis of representative components of Xin-Nao-Kang Capsule, a traditional Chinese medicinal formula, by UHPLC-Q-TOF-MS and UHPLC-TQ-MS."J Pharmaceut Biomed. 2021 May;198:114002

70. [IF=3.935] Tong Xie et al."A post processing strategy to score and rank the annotation confidence of saponins in natural products by integrating MS2 spectral similarity and fragment interpretation."J Pharmaceut Biomed. 2021 Sep;204:114291

69. [IF=3.935] Pengcheng Huang et al."Correlation study between the pharmacokinetics of seven main active ingredients of Mahuang decoction and its pharmacodynamics in asthmatic rats."J Pharmaceut Biomed. 2020 May;183:113144

68. [IF=4.225] Wei Wenyang et al."Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A."Front Pharmacol. 2019 Sep;0:961

67. [IF=4.36] Li-Mei Feng et al."An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropathic pain by the combination of partial least-squares regression and multi-index comprehensive method."J Ethnopharmacol. 2020 Oc

66. [IF=4.36] Li Lin et al."Study on the alleviation of Fengshi Gutong capsule on rheumatoid arthritis through integrating network pharmacology and experimental exploration."J Ethnopharmacol. 2021 Nov;280:114471

65. [IF=4.749] Bin Wei et al."Highly Selective Entrapment of His-Tagged Enzymes on Superparamagnetic Zirconium-Based MOFs with Robust Renewability to Enhance pH and Thermal Stability."Acs Biomater Sci Eng. 2021;7(8):3727–3736

64. [IF=5.34] Jing Zhang et al."Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule."Phytomedicine. 2020 Oct;77:153273

63. [IF=5.455] Yu Yunru et al."Identification of anti-inflammatory compounds from Zhongjing formulae by knowledge mining and high-content screening in a zebrafish model of inflammatory bowel diseases."Chin Med-Uk. 2021 Dec;16(1):1-14

62. [IF=5.64] Ting Li et al."Dynamic Changes in Endophytic Microorganisms and Metabolites During Natural Drying of Licorice."Front Microbiol. 2021; 12: 740721

61. [IF=5.81] Cui Lihua et al."Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway."Front Pharmacol. 2021 Jun;0:1369

60. [IF=5.81] Chenning Zhang et al."Global Analysis the Potential Medicinal Substances of Shuangxia Decoction and the Process In Vivo via Mass Spectrometry Technology."Front Pharmacol. 2021; 12: 654807

59. [IF=5.893] Ruocong Yang et al."Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study."Pharmacol Res. 2020 Jul;157:104820

58. [IF=2.441] Zhang Wen et al."Hepatic Uptake Mechanism of Ophiopogonin D Mediated by Organic Anion Transporting Polypeptides."Eur J Drug Metab Ph. 2017 Aug;42(4):669-676

57. [IF=3] Han CHEN et al."Chemical profile of the active fraction of Yi-Gan San by HPLC-DAD-Q-TOF-MS and its neuroprotective effect against glutamate-induced cytotoxicity."Chin J Nat Medicines. 2014 Nov;12:869

56. [IF=3.205] Zhuangzhuang Li et al."Simultaneous quantification of fifteen compounds in rat plasma by LC-MS/MS and its application to a pharmacokinetic study of Chaihu-Guizhi decoction."J Chromatogr B. 2019 Jan;1105:15

55. [IF=3.361] Lailai Li et al."Development of a dual screening strategy to identify pro-angiogenic compounds from natural products: application on Tongmai Yangxin Pills."Rsc Adv. 2016 Dec;6(116):115308-115316

54. [IF=3.414] Mengkai Zheng et al."Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model."J Ethnopharmacol. 2015 Apr;164:22

53. [IF=3.922] Wei Wang et al."Peony-Glycyrrhiza Decoction, an Herbal Preparation, Inhibits Clozapine Metabolism via Cytochrome P450s, but Not Flavin-Containing Monooxygenase in In Vitro Models."Drug Metab Dispos. 2015 Jul;43(7):1147-1153

52. Yang, Ruocong, et al. "Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): in silico and experimental study." Pharmacological research 157 (2020): 104820.h

51. Zheng, Mengkai, et al. "Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model." Journal of ethnopharmacology 164 (2015): 22-29.https://

50. Wei Wang, Dan-Dan Tian, Bin Zheng, Di Wang, Qing-Rong Tan, Chuan-Yue Wang and Zhang-Jin Zhang Drug Metabolism and Disposition July 2015, 43 (7) 1147-1153; DOI: https://doi.org/10.1124/dmd.114.062653

49. Han, C. H. E. N., et al. "Chemical profile of the active fraction of Yi-Gan San by HPLC-DAD-Q-TOF-MS and its neuroprotective effect against glutamate-induced cytotoxicity." Chinese journal of natural medicines 12.11 (2014): 869-880.https://doi.org/10.1016/

48. Tang Y, Zheng M, Chen YL, Chen J, He Y. Pharmacokinetic Effects of Cinnamic Acid, Amygdalin, Glycyrrhizic Acid and Liquiritin on Ephedra Alkaloids in Rats. European Journal of Drug Metabolism and Pharmacokinetics. 2017 Jun;42(3):527-535. DOI: 10.1007/s1331

47. Yu, Yunru, et al. "Identification of anti-inflammatory compounds from Zhongjing formulae by knowledge mining and high-content screening in a zebrafish model of inflammatory bowel diseases." Chinese medicine 16.1 (2021): 1-14.

46. Zhang, Wen, et al. "Hepatic uptake mechanism of ophiopogonin d mediated by organic anion transporting polypeptides." European journal of drug metabolism and pharmacokinetics 42.4 (2017): 669-676.

45. Liu, J., Guo, Y., Xu, Y. et al. Scutellarin is Highly Likely to be Responsible for Drug-Drug Interactions Mediated by Hepatic Organic Anion-Transporting Polypeptide1B3. Pharm Res 37, 232 (2020). https://doi.org/10.1007/s11095-020-02950-5

44. Li-Mei Feng, Yan-Yan Chen, Ding-Qiao Xu, Rui-Jia Fu, Shi-Jun Yue, Qi Zhao, Yu-Xi Huang, Xue Bai, Mei Wang, Li-Ming Xing, Yu-Ping Tang, Jin-Ao Duan, An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropa

43. Li-Mei Feng, Yan-Yan Chen, Ding-Qiao Xu, Rui-Jia Fu, Shi-Jun Yue, Qi Zhao, Yu-Xi Huang, Xue Bai, Mei Wang, Li-Ming Xing, Yu-Ping Tang, Jin-Ao Duan, An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropa

42. Wang, Xiaoping, et al. "Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats." Journal of ethnopharmacology 252 (2020): 112536.https://doi.org/10.1016/j.jep.2019.112536

41. 敏,王猛猛,吴雨,陈文文,王之通,张磊阳,蒋健.补中益气汤6个成分在大鼠体内的药代动力学研究[J].辽宁中医杂志,2020,47(11):159-163.

40. 纪万里,周泽华,王婷婷,安叡,梁琨,王新宏.基于UPLC-LTQ-Orbitrap-MS方法分析半夏泻心汤化学成分[J].药物分析杂志,2020,40(10):1736-1750.

39. 薛梦洁,于卉娟,王璐瑶,柴欣,杨静,王跃飞.血府逐瘀汤提取过程中成分的量变规律研究[J].天津中医药,2021,38(01):109-112.

38. 徐芳芳,张秀莉,侯滔,曲腊腊,王纪霞,刘艳芳,梁鑫淼.天然产物中FFA1受体新激动剂的发现与研究[J].上海中医药大学学报,2021,35(01):12-19. [4]宫梦琪,孙倩,李振.天麻中天麻素提取工艺优化及抑制α-葡萄糖苷酶活性研究[J].中国果菜,2020,40(09):14-17+23.

37. 任少东,王群霞,任晓镤.不同抗氧化剂对烤肉制品品质的影响[J].肉类研究,2020,34(08):21-28.

36. 黄玉宇,陈汀,沈夕坤,李梅珍,胡一丹,沈晗.当归建中汤加水量参数的多指标正交试验优选[J].时珍国医国药,2020,31(08):1892-1894.

35. 刘月波章小敏洪冰等. HPLC-DAD法比较不同剂型麻黄汤及其拆方中有效成分含量[J]. 中国中医药科技 2020(1).

34. 万嘉洋, 田彦芳, 万海同,等. 麻黄汤有效组分配伍在发热大鼠体内的药动学研究[J]. 中国中药杂志, 2019(10).

33. 李娅琦, 王梓轩, 肖治均,等. 猪胆粉主要胆酸类成分的定性定量分析[J]. 中国中药杂志, 2019(9).

32. 李娅琦, 王梓轩, 关彦玲,等. 护肝片中两种主要结合型胆酸的HPLC-ELSD含量测定[J]. 中国药师, 2019, 022(002):350-352.

31. 王亚洲, 吕建伟. 抗乳腺小叶增生合剂的质量标准研究[J]. 中国药房, 2012(23):2165-2167.

30. 杨春梅曹唯仪侯俊玲等. 丹酚酸B、芍药苷和甘草酸复配在大鼠体内的药动学参数研究[J]. 西北药学杂志 2018 33(03):94-99.

29. 杨春梅曹唯仪林珈好等. SPG复方主要成分配伍给药在大鼠体内药动学参数研究[J]. 辽宁中医药大学学报 2018 020(010):32-35.

28. 李煌, 马黄璜, 乔丽菲,等. 栝楼桂枝滴丸质量标准及体外溶出度研究[J]. 中国中医药信息杂志, 2017, 024(009):80-83.

27. 杨梦玲, 尤朋涛, 何丽珊,等. 基于UPLC-MS/MS分析胃溃疡模型大鼠口服加味小柴胡颗粒后血浆中8种有效成分的药代动力学[J]. 中国中药杂志, 2018, 43(18).

26. 李恋曲, 季律, 魏盼,等. 麻黄-甘草药对抑制Th2型变应性接触性皮炎的作用及机制探讨[J]. 南京中医药大学学报, 2018(3).

25. 魏盼, 季律, 袁为远,等. 麻黄-甘草药对对小鼠脾细胞的增殖以及Th1/Th2平衡的影响[J]. 南京中医药大学学报, 2018, 34(004):371-375,380.

24. 卜洪鹏, 李凌军, 孙京海,等. 高效液相色谱波长切换法同时测定四妙勇安颗粒中6个主要成分的含量[J]. 中南药学, 2016(1):69-73.

23. 莫雨佳, 王彦, 齐琪,等. 经典名方散偏汤HPLC指纹图谱的建立及川芎的量值传递研究[J]. 中国中药杂志, 2020, v.45(03):122-128.

22. 赵鑫,张艳雪,李丽,吴鹏,武毅,孙阳恩,齐晓丹,张学兰.甘草饮片炮制工艺的优选[J].山东中医杂志,2020,39(07):726-731.

21. 潘博宇, 王荷花, 张小骥,等. 甘草酸,甘草苷对肿瘤细胞中硫氧还蛋白的核定位影响及其临床意义[J]. 华中科技大学学报(医学版), 2016, 45(002):181-184.

20. 马建萍, 骆晓婷, 钟懿聪,等. 甘草酸-壳聚糖偶联物的合成及体外细胞摄取研究[J]. 中国药学杂志, 2017, 52(006):442-446.

19. 罗静雯, 姚文杰, 孙蒋,等. 甘草酸-低分子壳聚糖偶联物大鼠体内组织分布研究[J]. 中国医院药学杂志, 2019(003):224-228.

18. 孙云波, 张创峰, 毕丹,等. 甘草超高液相色谱指纹图谱研究[J]. 中国中医药信息杂志, 2020.

17. 姚庆收, 陈向明, 丁斐,等. 甘草毛状根遗传转化体系的建立及甘草酸和总黄酮含量的测定[J]. 中药材, 2018, 041(009):2035-2038.

16. 程丽娜, 曹世杰, 曲明,等. 甘草主要成分改善L6大鼠成肌细胞胰岛素抵抗的机制[J]. 中国实验方剂学杂志, 2020(4).

15. 权彦, 马天柱, 王枭洋. 甘草-黄芪组方中美白成分的提取及活性检测[J]. 当代化工, 2019(9).

14. 蔡鹰, 陆瑜, 邱蓉丽,等. 消银解毒袋煎剂的HPLC-DAD指纹图谱研究[J]. 中药材, 2015, 38(009):1964-1968.

13. 李灿, 唐利军, 茹琴,等. 戒毒一号的高效液相色谱指纹图谱研究[J]. 江汉大学学报(自然科学版), 2018, 46(05):471-476.

12. 乔丽菲, 孙承韬, 王宏运,等. 复方栝楼桂枝汤的大孔树脂纯化工艺研究[J]. 江西中医药, 2017, 07(v.26;No.303):57-61.

11. 梁霞, 吕晓玲. 复合酶和超声辅助两步法提取甘草酸的工艺[J]. 食品与机械, 2018, 034(010):145-151,157.

10. 李欢欢, 林丽, 郭爽,等. 基于网络药理学及定性定量研究的甘草质量标志物预测分析[J]. 中草药, 2020, v.51;No.669(10):93-101.

9. 田彦芳,万海同,朱紫烨,郑平平,虞立,何昱.基于熵权法的多目标筛选甘草黄酮类成分纯化工艺[J].中草药,2016,47(07):1118-1125.

8. 刘效栓,肖正国,罗燕燕,李喜香,李季文,毕映燕,刘军刚.基于指纹图谱与一测多评技术分析化学转化法富集甘草药渣总黄酮的研究[J].中国中医药信息杂志,2018,25(01):69-73.

7. 钱凯杨德森毛芬兰等. 人中黄的高效液相色谱指纹图谱研究[J]. 时珍国医国药 2017 028(005):1125-1127.

6. 王胜超张振凌刘艳等. 人中黄炮制前后6种化学成分的含量变化及其质量评价[J]. 中国实验方剂学杂志 2017 023(009):11-16.

5. 罗琳张豆豆李文斌等. 不同产地栽培甘草药用部位性状和质量的比较分析[J]. 中药材 2018 041(004):829-833.

4. 张会平蔡丽侠于文帅等. UPLC法研究甘草京大戟反药对配伍后京大戟对甘草中有效成分含量的影响[J]. 沈阳药科大学学报 2019.

3. 王子凌云梁琨李国文. HPLC法测定芩杏清热止咳颗粒中8种成分[J]. 中成药 2019 041(005):995-999.

2. 蔡明. HPLC法测定抗乳腺小叶增生合剂中甘草酸的含量[J]. 齐齐哈尔医学院学报(23):3874-3875.

1. 朱紫烨田彦芳张迁等. BP神经网络结合熵权法优化甘草皂苷提取工艺[J]. 中成药 2017 039(009):1830-1834.

Glycyrrhizic acid 甘草酸; Glycyrrhizin,98.0%

Glycyrrhizic acid 甘草酸; Glycyrrhizin

化学品安全说明书(MSDS)

质检证书(COA)

1. 物质的识别

2. 合成/成分数据

3. 急救措施

4. 消防措施

5. 泄漏应急处理

6. 处理和储存

7. 接触控制和个人防护

8. 稳定性和反应活性

9. 毒性资料

10. 生态资料

11. 废弃处置

12. 运输信息

13. 法规信息

14. 其他信息

在线咨询